Summary

Europe veterinary medicine market is expected to reach USD 21.47 billion by 2032 from USD 13.18 billion in 2024, growing at a CAGR of 6.3% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Veterinary Medicine Market, By Type (Therapeutics and Diagnostics), Application (Bacterial Diseases, Canine Atopic Dermatitis, Heminthes Infection, Animal Cancer, Foot and Mouth Disease, Autoimmune Diseases, Bluetongue, and Others), Animal Type (Companion Animals and Production Animal), End User (Veterinary Hospitals, Veterinary Clinics, Animal And Veterinary Farms, Reference Laboratories, Academic And Research Institute, Point-Of-Care Testing/In-House Testing, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Austria, Ireland, Norway, Poland, and Rest of Europe) - Industry Trends & Forecast To 2032
Overview of the Europe Veterinary Medicine Market are:

Driver

• Increasing Pet Ownership Boosts Demand For Veterinary Services

Restrain

• High Veterinary Care Costs Limit Market Accessibility
Opportunity

• Increasing Number of Animals Leading to The Demand Of Veterinary Medicine

Market Players:

The key market players for Europe veterinary medicine market are listed below:


• Zoetis Services LLC
• Merck & Co., Inc.
• Elanco or its affiliates
• C.H. Boehringer Ingelheim International GmbH
• IDEXX LABORATORIES, INC
• AB Science
• AdvaCare Pharma
• ALMAX IMAGING srl
• Anivive
• BIOMÉRIEUX
• Bionote USA Inc.
• Bio-Rad Laboratories, Inc.
• CANON MEDICAL SYSTEMS EUROPE B.V.
• Cargill, Incorporated
• Ceva
• CureLab Oncology
• Dechra Pharmaceuticals Limited
• Narang Medical Limited
• Neogen Corporation
• NIPPON ZENYAKU KOGYO CO., LTD.
• Demeditec Diagnostics GmbH
• DHN International
• Diagnostic Imaging Systems
• ESAOTE SPA
• Eurofins Scientific
• Evonik Industries AG
• FUJIFILM Holdings Corporation
• Gold Standard Diagnostics
• Hallmarq Veterinary Imaging
• Hebei Veyong Pharmaceutical Co., Ltd.
• IBIS S.R.L.
• Virbac
• Nutreco
• PLANMECA OΥ
• Randox Laboratories Ltd.
• Torigen Pharmaceuticals Inc.
• Thermo Fisher Scientific Inc.
• Vetoquinol

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 71
1.1 OBJECTIVES OF THE STUDY 71
1.2 MARKET DEFINITION 71
1.3 OVERVIEW OF THE EUROPE VETERINARY MEDICINE MARKET 71
1.4 CURRENCY AND PRICING 74
1.5 LIMITATIONS 74
1.6 MARKETS COVERED 74
2 MARKET SEGMENTATION 82
2.1 MARKETS COVERED 82
2.2 GEOGRAPHICAL SCOPE 83
2.3 YEARS CONSIDERED FOR THE STUDY 84
2.4 DBMR TRIPOD DATA VALIDATION MODEL 85
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 88
2.6 MULTIVARIATE MODELLING 89
2.7 DBMR MARKET POSITION GRID 90
2.8 MARKET END USER COVERAGE GRID 91
2.9 VENDOR SHARE ANALYSIS 92
2.10 SECONDARY SOURCES 93
2.11 ASSUMPTIONS 93
3 EXECUTIVE SUMMARY 94
4 PREMIUM INSIGHTS 103
4.1 PESTAL ANALYSIS 105
4.2 PORTERS FIVE FORCES ANALYSIS 106
4.3 PIPELINE ANALYSIS 107
4.4 TOP ENTITIES BASED ON R&D GLANCE FOR VETERINARY MEDICINE MARKET 108
4.5 EPIDEMIOLOGY 109
5 EUROPE VETERINARY MEDICINE MARKET: REGULATIONS 110
6 MARKET OVERVIEW 112
6.1 DRIVERS 114
6.1.1 INCREASING PET OWNERSHIP BOOSTS DEMAND FOR VETERINARY SERVICES 114
6.1.2 RISING ANIMAL DISEASES DRIVE NEED FOR ADVANCED VETERINARY CARE 115
6.1.3 VETERINARY MEDICINE ADVANCES IMPROVE DIAGNOSIS AND TREATMENT OPTIONS 115
6.1.4 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS INCREASES VETERINARY NEEDS 116
6.2 RESTRAINTS 118
6.2.1 HIGH VETERINARY CARE COSTS LIMIT MARKET ACCESSIBILITY 118
6.2.2 LACK OF AWARENESS ABOUT ANIMAL HEALTH LIMITS PROPER VETERINARY CARE ACCESS 118
6.3 OPPORTUNITIES 120
6.3.1 INCREASING NUMBER OF ANIMALS LEADING TO THE DEMAND OF VETERINARY MEDICINE 120
6.3.2 GROWTH IN ANIMAL HEALTH BIOTECHNOLOGY 120
6.3.3 GROWTH IN DEMAND FOR NUTRITIONAL SUPPLEMENTS 121
6.4 CHALLENGES 122
6.4.1 CHALLENGES OF REGULATORY COMPLIANCE AND COMPLEXITY 122
6.4.2 SHORTAGE OF VETERINARY PROFESSIONALS 122
7 EUROPE VETERINARY MEDICINE MARKET, BY TYPE 124
7.1 OVERVIEW 125
7.2 THERAPEUTICS 128
7.2.1 PHARMACEUTICALS 130
7.2.1.1 ANTIBIOTICS 131
7.2.1.1.1 TETRACYCLINE 131
7.2.1.1.2 PENICILLINS 131
7.2.1.1.3 MACROLIDES 131
7.2.1.1.4 AMINOGLYCOSIDES 131
7.2.1.1.5 LINCOSAMIDES 131
7.2.1.1.6 COLISTIN 131
7.2.1.1.7 OTHERS 131
7.2.1.2 PARASITICIDES 132
7.2.1.2.1 BENZIMIDAZOLES 132
7.2.1.2.2 MACROCYCLIC LACTONES 132
7.2.1.2.3 PYRETHROIDS 132
7.2.1.2.4 AMPROLIUM 132
7.2.1.2.5 NITROIMIDAZOLES 132
7.2.1.2.6 PIPERAZINE 132
7.2.1.2.7 OTHERS 132
7.2.1.3 ANALGESICS/ANTI-INFLAMMATORY (NSAIDS) 133
7.2.1.3.1 CARPROFEN 133
7.2.1.3.2 MELOXICAM 133
7.2.1.3.3 PHENYLBUTAZONE 133
7.2.1.3.4 ACETAMINOPHEN 133
7.2.1.3.5 FIROCOXIB 133
7.2.1.3.6 DERACOXIB 133
7.2.1.3.7 OTHERS 133
7.2.1.4 ANTIHISTAMINES 134
7.2.1.4.1 CETIRIZINE 134
7.2.1.4.2 BROMPHENIRAMINE 134
7.2.1.4.3 DIPHENHYDRAMINE 134
7.2.1.4.4 TERFENADINE 134
7.2.1.4.5 TRIMEPRAZINE 134
7.2.1.4.6 OTHERS 134
7.2.1.5 CORTICOSTEROIDS 135
7.2.1.5.1 DEXAMETHASONE 135
7.2.1.5.2 PREDNISOLONE 135
7.2.1.5.3 PREDNISONE 135
7.2.1.5.4 OTHERS 135
7.2.1.6 ANTIBLOAT 136
7.2.1.6.1 DOCUSATE 136
7.2.1.6.2 SIMETHICONE 136
7.2.1.6.3 OTHERS 136
7.2.1.7 HORMONAL 137
7.2.1.7.1 EQUINE CHORIONIC GONADOTROPIN 137
7.2.1.7.2 CLOPROSTENOL 137
7.2.1.7.3 OXYTOCIN 137
7.2.1.7.4 OTHERS 137
7.2.1.8 OPIOIDS 138
7.2.1.8.1 MU AGONISTS 138
7.2.1.8.1.1 METHADONE 139
7.2.1.8.1.2 MEPERIDINE 139
7.2.1.8.1.3 MORPHINE 139
7.2.1.8.1.4 OXYMORPHONE 139
7.2.1.8.1.5 OTHERS 139
7.2.1.8.2 PARTIAL MU AGONIST 140
7.2.1.8.2.1 BUPRENORPHINE 140
7.2.1.8.2.2 OTHERS 140
7.2.1.8.3 KAPPA AGONIST-MU ANTAGONIST 140
7.2.1.8.3.1 BUTORPHANOL 140
7.2.1.8.3.2 OTHERS 140
7.2.1.9 OTHERS 141
7.2.1.10 PHARMACEUTICALS BY DRUG TYPE 141
7.2.1.10.1 BRANDED 141
7.2.1.10.2 GENERIC 141
7.2.1.11 PHARMACEUTICALS BY PRESCRIPTION MODE 141
7.2.1.11.1 PRESCRIPTION BASED 141
7.2.1.11.2 OVER THE COUNTER 141
7.2.1.12 PHARMACEUTICALS BY ROUTE OF ADMINISTRATION, 142
7.2.1.12.1 ORAL 142
7.2.1.12.1.1 TABLETS 143
7.2.1.12.1.2 SOLUTIONS 143
7.2.1.12.1.3 POWDER 143
7.2.1.12.1.4 OTHERS 143
7.2.1.12.2 PARENTAL 143
7.2.1.12.2.1 INTRAVENOUS 143
7.2.1.12.2.2 SUBCUTANEOUS 143
7.2.1.12.2.3 OTHERS 143
7.2.1.12.3 TOPICAL 143
7.2.1.12.4 OTHERS 143
7.2.2 VACCINES 144
7.2.2.1 LIVE ATTENUATED VACCINES 144
7.2.2.2 TOXOID VACCINES 144
7.2.2.3 RECOMBINANT VACCINES 144
7.2.2.4 INACTIVATED VACCINES 144
7.2.2.5 OTHERS 144
7.2.3 BIOLOGICS 145
7.2.3.1 MARKETED 145
7.2.3.1.1 TOCERANIB 146
7.2.3.1.2 LOMUSTINE 146
7.2.3.1.3 CYCLOPHOSPHAMIDE 146
7.2.3.1.4 CHLORAMBUCIL 146
7.2.3.1.5 OTHERS 146
7.2.3.2 EMERGING 146
7.2.4 MEDICATED FEED ADDITIVES 147
7.2.4.1 ENZYMES 148
7.2.4.1.1 PHYTASE 149
7.2.4.1.2 CARBOHYDRASE 149
7.2.4.1.3 PROTEASE 149
7.2.4.1.4 AMYLASE 149
7.2.4.1.5 CELLULASE 149
7.2.4.1.6 MANNASE 149
7.2.4.1.7 GLUCANASE 149
7.2.4.1.8 XYLANASE 149
7.2.4.1.9 OTHERS 149
7.2.4.2 AMINO ACID 150
7.2.4.2.1 LYSINE 150
7.2.4.2.2 METHIONINE 150
7.2.4.2.3 THREONINE 150
7.2.4.2.4 TRYPTOPHAN 150
7.2.4.2.5 OTHERS 150
7.2.4.3 VITAMINS 151
7.2.4.3.1 FAT-SOLUBLE VITAMIN 151
7.2.4.3.1.1 VITAMIN A 152
7.2.4.3.1.2 VITAMIN E 152
7.2.4.3.1.3 VITAMIN D 152
7.2.4.3.1.4 VITAMIN K 152
7.2.4.3.2 WATER-SOLUBLE VITAMIN 152
7.2.4.3.2.1 VITAMIN B COMPLEX 152
7.2.4.3.2.2 VITAMIN C 152
7.2.4.4 ANTIOXIDANTS 153
7.2.4.4.1 BHA 153
7.2.4.4.2 BHT 153
7.2.4.4.3 ETHOXYQUIN 153
7.2.4.4.4 OTHERS 153
7.2.4.5 PROBIOTICS 154
7.2.4.6 LACTOBACILLI 154
7.2.4.7 BIFIDOBACTERIA 154
7.2.4.8 YEAST 154
7.2.4.9 STRETOCOCCUS THERMOPHILUS 154
7.2.4.10 FEED ACIDIFIERS 155
7.2.4.10.1 PROPIONIC ACID 155
7.2.4.10.2 FORMIC ACID 155
7.2.4.10.3 LACTIC ACID 155
7.2.4.10.4 CITRIC ACID 155
7.2.4.10.5 OTHERS 155
7.2.4.11 MYCOTOXIN DETOXIFIERS 156
7.2.4.11.1 MYCOTOXIN BINDERS 156
7.2.4.11.1.1 SILICATES 157
7.2.4.11.1.2 CLAYS 157
7.2.4.11.1.3 CHEMICAL POLYMERS 157
7.2.4.11.1.4 GLUCAN PRODUCTS 157
7.2.4.11.1.5 OTHERS 157
7.2.4.11.2 MYCOTOXIN MODIFIERS 157
7.2.4.12 PHYTOGENIC 158
7.2.4.12.1 ESSENTIAL OILS 158
7.2.4.12.2 HERBS & SPICES 158
7.2.4.12.3 OLEORESIN 158
7.2.4.12.4 OTHERS 158
7.2.4.13 CAROTENOIDS 159
7.2.4.13.1 BETA-CAROTENE 159
7.2.4.13.2 ASTAXANTHIN 159
7.2.4.13.3 LUTEIN 159
7.2.4.13.4 CANTHAXANTHIN 159
7.2.4.14 TRACE MINERALS 160
7.2.4.14.1 ZINC 160
7.2.4.14.2 COPPER 160
7.2.4.14.3 MANGANESE 160
7.2.4.14.4 IRON 160
7.2.4.14.5 SELENIUM 160
7.2.4.14.6 OTHERS 160
7.2.4.15 PRESERVATIVES 161
7.2.4.15.1 ANTICAKING AGENTS 161
7.2.4.15.2 MOLD INHIBITORS 161
7.2.4.16 FLAVOURS AND SWEETENERS 162
7.2.4.16.1 FLAVORS 162
7.2.4.16.2 SWEETENERS 162
7.2.4.16.2.1 SACCHARIN 163
7.2.4.16.2.2 NEOHESPERIDIN DIHYDROCHALCONE 163
7.2.4.16.2.3 GLYCYRRHIZIN 163
7.2.4.16.2.4 THAUMATIN 163
7.2.4.16.2.5 OTHERS 163
7.2.4.17 OTHERS 163
7.3 DIAGNOSTICS 164
7.3.1 INSTRUMENTS & DEVICES 165
7.3.1.1 IMAGING DEVICES 165
7.3.1.2 X-RAY IMAGING (RADIOGRAPHY) 166
7.3.1.2.1 SMALL ANIMALS 166
7.3.1.2.2 LARGE ANIMALS 166
7.3.1.3 ULTRASOUND 166
7.3.1.3.1 SMALL ANIMALS 166
7.3.1.3.2 LARGE ANIMALS 166
7.3.1.4 COMPUTED TOMOGRAPHY 167
7.3.1.4.1 SMALL ANIMALS 167
7.3.1.4.2 LARGE ANIMALS 167
7.3.1.5 MAGNETIC RESONANCE IMAGING 167
7.3.1.5.1 SMALL ANIMALS 167
7.3.1.5.2 LARGE ANIMALS 167
7.3.1.6 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 168
7.3.1.6.1 SMALL ANIMALS 168
7.3.1.6.2 LARGE ANIMALS 168
7.3.1.6.3 OTHERS 168
7.3.2 LABORATORY INSTRUMENTS 169
7.3.2.1 HEMATOLOGY ANALYZERS 170
7.3.2.1.1 BY MODE 170
7.3.2.1.1.1 AUTOMATIC 170
7.3.2.1.1.2 SEMI-AUTOMATIC 170
7.3.2.1.2 BY PRICE RANGE 170
7.3.2.1.2.1 HIGH PRICE RANGE 170
7.3.2.1.2.2 STANDARD PRICE RANGE 170
7.3.2.1.3 BY MODALITY, 171
7.3.2.1.3.1 BENCHTOP 171
7.3.2.1.3.2 PORTABLE 171
7.3.2.1.3.3 OTHERS 171
7.3.2.2 CHEMISTRY ANALYZERS 172
7.3.2.2.1 BY MODE 172
7.3.2.2.1.1 AUTOMATIC 172
7.3.2.2.1.2 SEMI-AUTOMATIC 172
7.3.2.2.2 BY MODALITY, 172
7.3.2.2.2.1 BENCHTOP 172
7.3.2.2.2.2 PORTABLE 172
7.3.2.2.3 BY SAMPLE TYPE, 173
7.3.2.2.3.1 BLOOD 173
7.3.2.2.3.2 URINE 173
7.3.2.2.3.3 STOOL 173
7.3.2.2.3.4 OTHERS 173
7.3.2.3 POINT-OF-CARE INSTRUMENTS 174
7.3.2.3.1 BY TYPE 174
7.3.2.3.1.1 LATERAL FLOW POCT 174
7.3.2.3.1.2 MOLECULAR POCT 174
7.3.2.3.1.3 OTHERS 174
7.3.2.3.2 BY MODE 175
7.3.2.3.2.1 AUTOMATIC 175
7.3.2.3.2.2 SEMI-AUTOMATIC 175
7.3.2.4 COAGULATION ANALYZERS 175
7.3.2.4.1 BY CHANNEL, 176
7.3.2.4.1.1.1 4-CHANNEL 176
7.3.2.4.1.1.2 1-CHANNEL 176
7.3.2.4.2 BY SAMPLE TYPE 176
7.3.2.4.2.1 WHOLE BLOOD 176
7.3.2.4.2.2 PLASMA 176
7.3.2.4.3 BY MODALITY, 177
7.3.2.4.3.1 BENCHTOP 177
7.3.2.4.3.2 PORTABLE 177
7.3.2.5 URINALYSIS EQUIPMENT 178
7.3.2.5.1 BY MODE 178
7.3.2.5.1.1 AUTOMATIC 178
7.3.2.5.1.2 SEMI-AUTOMATIC 178
7.3.2.6 REFRACTOMETER 178
7.3.2.6.1 BY MODE, 178
7.3.2.6.1.1 OPTICAL 179
7.3.2.6.1.2 DIGITAL 179
7.3.2.6.2 BY MODALITY, 179
7.3.2.6.2.1 BENCHTOP 179
7.3.2.6.2.2 PORTABLE 179
7.3.2.7 OTHERS 179
7.3.3 REAGENTS & CONSUMABLES 180
7.3.3.1 KITS 181
7.3.3.1.1 PCR KITS 181
7.3.3.1.2 RAPID TEST KITS 181
7.3.3.1.3 MULTIPLEX KITS 181
7.3.3.1.4 ELISA KITS 181
7.3.3.1.5 SAMPLE PREPARATION KITS ISOLATION AND EXTRACTION KITS 181
7.3.3.1.6 OTHERS 181
7.3.3.2 REAGENTS 182
7.3.3.2.1 NUCLEIC ACID EXTRACTION REAGENTS 182
7.3.3.2.2 IMMUNOFLUORESCENCE REAGENTS 182
7.3.3.2.3 COOMBS REAGENTS 182
7.3.3.2.4 OTHERS REAGENTS 182
7.3.4 MEDIA 182
7.3.5 PANEL 182
7.3.6 STRIPS 182
7.3.7 CASSETTE 182
7.3.8 CONTROL STANDARDS 182
7.3.9 PROBES AND PRIMER 182
7.3.10 OTHERS CONSUMABLE AND ACCESSORIES 182
8 EUROPE VETERINARY MEDICINE MARKET, BY APPLICATION 183
8.1 OVERVIEW 184
8.2 BACTERIAL DISEASES 188
8.2.1 PRODUCTION ANIMALS 188
8.2.2 COMPANION ANIMALS 188
8.3 CANINE ATOPIC DERMATITIS 189
8.3.1 COMPANION ANIMALS 189
8.3.2 PRODUCTION ANIMALS 189
8.4 HEMINTHES INFECTION 190
8.4.1 PRODUCTION ANIMALS 190
8.4.2 COMPANION ANIMALS 190
8.5 ANIMAL CANCER 191
8.5.1 COMPANION ANIMALS 191
8.5.2 PRODUCTION ANIMALS 191
8.6 FOOT AND MOUTH DISEASE 192
8.6.1 PRODUCTION ANIMALS 192
8.6.2 COMPANION ANIMALS 192
8.7 AUTOIMMUNE DISEASES 193
8.7.1 COMPANION ANIMALS 193
8.7.2 PRODUCTION ANIMALS 193
8.8 BLUETONGUE 194
8.8.1 PRODUCTION ANIMALS 194
8.8.2 COMPANION ANIMALS 194
8.9 OTHERS 195
8.9.1 COMPANION ANIMALS 195
8.9.2 PRODUCTION ANIMAL 195
9 EUROPE VETERINARY MEDICINE MARKET, BY ANIMAL TYPE 196
9.1 OVERVIEW 197
9.2 COMPANION ANIMALS 200
9.2.1 DOGS 201
9.2.2 CATS 201
9.2.3 HORSES 201
9.2.4 OTHERS 201
9.3 PRODUCTION ANIMAL 202
9.3.1 POULTRY 203
9.3.2 CATTLE 203
9.3.3 SWINE 203
9.3.4 FISH 203
9.3.5 SHEEP & GOATS 203
9.3.6 OTHERS 203
10 EUROPE VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL 204
10.1 OVERVIEW 205
10.2 RETAIL SALES 208
10.2.1 OFFLINE 209
10.2.1.1 HOSPITAL PHARMACY 209
10.2.1.2 RETAIL PHARMACY 209
10.2.2 ONLINE 210
10.2.2.1 E-COMMERCE PLATFORMS 210
10.2.2.2 COMPANY WEBSITE 210
10.2.2.3 OTHERS 210
10.3 DIRECT TENDER 211
10.4 OTHERS 212
11 EUROPE VETERINARY MEDICINE MARKET, BY END USER 213
11.1 OVERVIEW 214
11.2 VETERINARY HOSPITALS 218
11.2.1 PRIVATE 218
11.2.2 PUBLIC 218
11.2.3 VETERINARY HOSPITALS BY LEVEL 219
11.2.3.1 TIER 2 219
11.2.3.2 TIER 1 219
11.2.3.3 TIER 3 219
11.3 VETERINARY CLINICS 220
11.3.1 VETERINARY CLINICS BY TYPE 220
11.3.1.1 PUBLIC 220
11.3.1.2 PRIVATE 220
11.4 ANIMAL AND VETERINARY FARMS 221
11.5 REFERENCE LABORATORIES 222
11.6 ACADEMIC AND RESEARCH INSTITUTE 223
11.7 POINT-OF-CARE TESTING/IN-HOUSE TESTING 224
11.8 OTHERS 225
12 EUROPE VETERINARY MEDICINE MARKET, BY REGION 226
12.1 EUROPE 228
12.1.1 GERMANY 260
12.1.2 FRANCE 289
12.1.3 U.K. 318
12.1.4 ITALY 346
12.1.5 SPAIN 375
12.1.6 RUSSIA 404
12.1.7 TURKEY 433
12.1.8 NETHERLANDS 462
12.1.9 SWITZERLAND 491
12.1.10 BELGIUM 520
12.1.11 REST OF EUROPE 549
13 EUROPE VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE 550
13.1 COMPANY SHARE ANALYSIS: GLOBAL 550
14 SWOT ANALYSIS 551
15 COMPANY PROFILES 552
15.1 ZOETIS SERVICES LLC SERVICES LLC. 552
15.1.1 COMPANY SNAPSHOT 552
15.1.2 REVENUE ANALYSIS 553
15.1.3 COMPANY SHARE ANALYSIS 553
15.1.4 PRODUCT PORTFOLIO 553
15.1.5 RECENT DEVELOPMENT 554
15.2 MERCK KGAA 556
15.2.1 COMPANY SNAPSHOT 556
15.2.2 REVENUE ANALYSIS 556
15.2.3 COMPANY SHARE ANALYSIS 557
15.2.4 PRODUCT PORTFOLIO 557
15.2.5 RECENT DEVELOPMENT 559
15.3 ELANCO OR ITS AFFILIATES. OR ITS AFFILIATES 560
15.3.1 COMPANY SNAPSHOT 560
15.3.2 REVENUE ANALYSIS 560
15.3.3 COMPANY SHARE ANALYSIS 561
15.3.4 PRODUCT PORTFOLIO 561
15.3.5 RECENT DEVELOPMENT 563
15.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 564
15.4.1 COMPANY SNAPSHOT 564
15.4.2 COMPANY SHARE ANALYSIS 564
15.4.3 PRODUCT PORTFOLIO 565
15.4.4 RECENT DEVELOPMENT 566
15.5 IDEXX LABORATORIES, INC 568
15.5.1 COMPANY SNAPSHOT 568
15.5.2 REVENUE ANALYSIS 568
15.5.3 COMPANY SHARE ANALYSIS 569
15.5.4 PRODUCT PORTFOLIO 569
15.5.5 RECENT DEVELOPMENT 571
15.6 AB SCIENCE 572
15.6.1 COMPANY SNAPSHOT 572
15.6.2 REVENUE ANALYSIS 572
15.6.3 PRODUCT PORTFOLIO 573
15.6.4 RECENT DEVELOPMENT 573
15.7 ADVACARE PHARMA 574
15.7.1 COMPANY SNAPSHOT 574
15.7.2 PRODUCT PORTFOLIO 574
15.7.3 RECENT DEVELOPMENT 575
15.8 ALMAX IMAGING SRL 576
15.8.1 COMPANY SNAPSHOT 576
15.8.2 PRODUCT PORTFOLIO 576
15.8.3 RECENT DEVELOPMENT 576
15.9 ANIVIVE 577
15.9.1 COMPANY SNAPSHOT 577
15.9.2 PRODUCT PORTFOLIO 577
15.9.3 RECENT DEVELOPMENT 580
15.10 BIOMÉRIEUX 581
15.10.1 COMPANY SNAPSHOT 581
15.10.2 REVENUE ANALYSIS 581
15.10.3 PRODUCT PORTFOLIO 582
15.10.4 RECENT DEVELOPMENT 582
15.11 BIONOTE USA INC. 583
15.11.1 COMPANY SNAPSHOT 583
15.11.2 PRODUCT PORTFOLIO 583
15.11.3 RECENT DEVELOPMENT 586
15.12 BIO-RAD LABORATORIES, INC. 587
15.12.1 COMPANY SNAPSHOT 587
15.12.2 REVENUE ANALYSIS 587
15.12.3 PRODUCT PORTFOLIO 588
15.12.4 RECENT DEVELOPMENT 590
15.13 CANON MEDICAL SYSTEMS EUROPE B.V. 591
15.13.1 COMPANY SNAPSHOT 591
15.13.2 REVENUE ANALYSIS 591
15.13.3 PRODUCT PORTFOLIO 592
15.13.4 RECENT DEVELOPMENT 592
15.14 CARGIL INCORPORATED 593
15.14.1 COMPANY SNAPSHOT 593
15.14.2 PRODUCT PORTFOLIO 593
15.14.3 RECENT DEVELOPMENT 595
15.15 CEVA 596
15.15.1 COMPANY SNAPSHOT 596
15.15.2 PRODUCT PORTFOLIO 596
15.15.3 RECENT DEVELOPMENT 598
15.16 CURELAB ONCOLOGY 599
15.16.1 COMPANY SNAPSHOT 599
15.16.2 PRODUCT PORTFOLIO 599
15.16.3 RECENT DEVELOPMENT 600
15.17 DECHRA PHARMACEUTICALS LIMITED 601
15.17.1 COMPANY SNAPSHOT 601
15.17.2 REVENUE ANALYSIS 601
15.17.3 PRODUCT PORTFOLIO 602
15.17.4 RECENT DEVELOPMENT 604
15.18 DEMEDITEC DIAGNOSTICS GMBH 605
15.18.1 COMPANY SNAPSHOT 605
15.18.2 PRODUCT PORTFOLIO 605
15.18.3 RECENT DEVELOPMENT 607
15.19 DHN 608
15.19.1 COMPANY SNAPSHOT 608
15.19.2 PRODUCT PORTFOLIO 608
15.19.3 RECENT DEVELOPMENT 610
15.20 DIAGNOSTIC IMAGING SYSTEMS 612
15.20.1 COMPANY SNAPSHOT 612
15.20.2 PRODUCT PORTFOLIO 612
15.20.3 RECENT DEVELOPMENT 614
15.21 ESAOTE SPA 615
15.21.1 COMPANY SNAPSHOT 615
15.21.2 PRODUCT PORTFOLIO 615
15.21.3 RECENT DEVELOPMENT 617
15.22 EUROFINS SCIENTIFIC 618
15.22.1 COMPANY SNAPSHOT 618
15.22.2 REVENUE ANALYSIS 619
15.22.3 PRODUCT PORTFOLIO 619
15.22.4 RECENT DEVELOPMENT 620
15.23 EVONIK ANIMAL NUTRITION 621
15.23.1 COMPANY SNAPSHOT 621
15.23.2 REVENUE ANALYSIS 621
15.23.3 1.1.3 PRODUCT PORTFOLIO 622
15.23.4 RECENT DEVELOPMENT 623
15.24 FUJIFILM HOLDINGS CORPORATION 624
15.24.1 COMPANY SNAPSHOT 624
15.24.2 REVENUE ANALYSIS 624
15.24.3 PRODUCT PORTFOLIO 625
15.24.4 RECENT DEVELOPMENT 628
15.25 GOLD STANDARD DIAGNOSTICS 629
15.25.1 COMPANY SNAPSHOT 629
15.25.2 PRODUCT PORTFOLIO 629
15.25.3 RECENT DEVELOPMENT 631
15.26 HALLMARQ VETERINARY IMAGING 632
15.26.1 COMPANY SNAPSHOT 632
15.26.2 PRODUCT PORTFOLIO 632
15.26.3 RECENT DEVELOPMENT 633
15.27 HEBEI VEYONG PHARMACEUTICAL CO., LTD. 634
15.27.1 COMPANY SNAPSHOT 634
15.27.2 PRODUCT PORTFOLIO 634
15.27.3 RECENT DEVELOPMENT 638
15.28 IBIS S.R.L. 639
15.28.1 COMPANY SNAPSHOT 639
15.28.2 PRODUCT PORTFOLIO 639
15.28.3 RECENT DEVELOPMENT 641
15.29 VIRBAC 642
15.29.1 COMPANY SNAPSHOT 642
15.29.2 REVENUE ANALYSIS 643
15.29.3 PRODUCT PORTFOLIO 643
15.29.4 RECENT DEVELOPMENT 646
15.30 VMRD, INC 647
15.30.1 COMPANY SNAPSHOT 647
15.30.2 PRODUCT PORTFOLIO 647
15.30.3 RECENT DEVELOPMENT 649
15.31 HESKA CORPORATION 650
15.31.1 COMPANY SNAPSHOT 650
15.31.2 REVENUE ANALYSIS 650
15.31.3 PRODUCT PORTFOLIO 651
15.31.4 RECENT DEVELOPMENT 652
15.32 KARYOPHARM 653
15.32.1 COMPANY SNAPSHOT 653
15.32.2 REVENUE ANALYSIS 653
15.32.3 PRODUCT PORTFOLIO 654
15.32.4 RECENT DEVELOPMENT 654
15.33 MERIDIAN BIOSCIENCE, INC 655
15.33.1 COMPANY SNAPSHOT 655
15.33.2 PRODUCT PORTFOLIO 655
15.33.3 RECENT DEVELOPMENT 656
15.34 NARANG MEDICAL LIMITED 657
15.34.1 COMPANY SNAPSHOT 657
15.34.2 PRODUCT PORTFOLIO 657
15.34.3 RECENT DEVELOPMENT 661
15.35 NEOGEN CORPORATION 662
15.35.1 COMPANY SNAPSHOT 662
15.35.2 REVENUE ANALYSIS 662
15.35.3 PRODUCT PORTFOLIO 663
15.35.4 RECENT DEVELOPMENT 665
15.36 NIPPON ZENYAKU KOGYO CO., LTD. 666
15.36.1 COMPANY SNAPSHOT 666
15.36.2 PRODUCT PORTFOLIO 666
15.36.3 RECENT DEVELOPMENT 667
15.37 VETDC 668
15.37.1 COMPANY SNAPSHOT 668
15.37.2 PRODUCT PORTFOLIO 668
15.37.3 RECENT DEVELOPMENT 669
15.38 NOVAVIVE INC. 670
15.38.1 COMPANY SNAPSHOT 670
15.38.2 PRODUCT PORTFOLIO 670
15.38.3 RECENT DEVELOPMENT 672
15.39 NUTRECO 673
15.39.1 COMPANY SNAPSHOT 673
15.39.2 PRODUCT PORTFOLIO 673
15.39.3 RECENT DEVELOPMENT 674
15.40 PLANMECA OY 675
15.40.1 COMPANY SNAPSHOT 675
15.40.2 PRODUCT PORTFOLIO 675
15.40.3 RECENT DEVELOPMENT 677
15.41 RANDOX LABORATORIES LTD. 678
15.41.1 COMPANY SNAPSHOT 678
15.41.2 PRODUCT PORTFOLIO 678
15.41.3 RECENT DEVELOPMENT 680
15.42 RINGPU BIOLOGY CO., LTD. 681
15.42.1 COMPANY SNAPSHOT 681
15.42.2 PRODUCT PORTFOLIO 681
15.42.3 RECENT DEVELOPMENT 684
15.43 SHENZHEN SONTU MEDICAL IMAGING EQUIPMENT CO., LTD 685
15.43.1 COMPANY SNAPSHOT 685
15.43.2 PRODUCT PORTFOLIO 685
15.43.3 RECENT DEVELOPMENT 687
15.44 THERMO FISHER SCIENTIFIC INC 688
15.44.1 COMPANY SNAPSHOT 688
15.44.2 REVENUE ANALYSIS 689
15.44.3 PRODUCT PORTFOLIO 689
15.44.4 RECENT DEVELOPMENT 690
15.45 TORIGEN PHARMACEUTICALS INC. 691
15.45.1 COMPANY SNAPSHOT 691
15.45.2 PRODUCT PORTFOLIO 691
15.45.3 RECENT DEVELOPMENT 692
16 QUESTIONNAIRE 693
17 RELATED REPORTS 696